AI Bioage Clocks, Retinal & Digital Twin Tools, Blood Biomarkers
Key Questions
What does Longevitix's AI platform offer to longevity clinics?
Longevitix launched an AI-powered platform that unifies patient data from wearables, labs, and medical history into personalized longevity plans. It targets medi-spas and direct primary care providers.
How is lower biological age linked to brain protection?
A new study links lower biological age to brain protection, showing a 41% lower stroke risk per incremental improvement. AI tools such as retinal imaging and MRI-based predictors further support early detection of conditions like Alzheimer's.
What blood biomarkers are used for early dementia detection?
Panels including p-tau217, GFAP, and NFL enable early-onset dementia detection, with combinations matching PET scan accuracy and achieving over 90% accuracy in some AI models. Beta-synuclein is also emerging as an early Alzheimer's biomarker.
How are digital twins being applied in aging and Alzheimer's research?
Digital twins are increasingly used for Alzheimer's cognitive monitoring and elderly care, with recent academic papers exploring language-based models for MCI. Consumer platforms and summits are highlighting their role alongside AI tools.
What new AI tools help predict frailty or mortality from routine scans?
Interpretable ML models like APLR use NHANES data for frailty risk prediction, while AI applied to thymus CT scans links organ health to heart disease and cancer risk. CT imaging biomarkers are emerging as scalable alternatives to omics clocks.
Longevitix launched AI-powered platform for longevity clinics to unify patient data (wearables, labs, history) into personalized plans, targeting medi-spas and direct primary care. New study links lower biological age to brain protection (41% lower stroke risk per jump). MetFoundation metabolomic model, Agediff, 150AGE ring, organ/ovarian twins; Nature Aging DL Alzheimer's predictor; UCSF/WVU MRI (92.8% AD), retinal AI, iAge; Google Co-Scientist aids senolytic discovery; explainable AI frailty prediction. AI4L open-source evidence review tool. Blood biomarker panel (p-tau217, GFAP, NFL) for early-onset dementia; p-tau217+another matches PET; GPND-AI >90% accuracy; ARIA blood test; beta-synuclein as early Alzheimer's biomarker. Major collaboration: Insilico Medicine and Human Longevity building first AI foundation model for longevity science. Human Life Foundation $599 WGS+AI. Cross-species transcriptomic integration revealed conserved mortality signatures and modular aging clocks (CDKN1A/LGALS3), with TACO online tool. Retinal age validated as systemic disease biomarker (MAE 2.78 years). Aubrey AI research copilot; ProtAIDe-Dx proteomics model differentiates six neurodegenerative conditions. Horvath's 353 CpG clock and GrimAge derivatives. New AI models (Stack, X-Cell, ESM2) simulate living cells for drug discovery. Kakao Ventures invested in Tab Zero (consumer digital twin). Gero named World Economic Forum 2026 Technology Pioneer and raised $17M (total $34M) for AI-driven aging modeling. New consumer AI platform 'Longevity or BS' launched. Digital twins increasingly discussed in Alzheimer's context; a recent academic paper explores language-based digital twins for elderly cognitive monitoring (MCI). ICC global longevity summit highlighted AI and human digital twins. New practical AI content: video guide on using Gemini and NotebookLM to interpret blood test results, interview with XPRIZE Healthspan participant Dr. Clinton Hughes. Mass General Brigham study applied AI to thymus CT scans, linking thymus health to heart disease and cancer risk. A scalable AI-guided multi-omic framework combining causal genetics to prioritize therapeutic targets. New: Latent Labs (Simon Kohl, ex-AlphaFold) building AI agents for drug design, compressing timelines from 18 months to one month. New: A liver aging clock using ML predicts all-cause mortality. A recent Nature Medicine study decoded cellular aging clocks from blood proteomics, revealing cell-type-specific risk predictions (astrocytes→Alzheimer's, muscle→ALS, respiratory→lung cancer). New: CT imaging biomarkers emerging as a practical, scalable alternative to expensive omics clocks, with AI extraction from routine scans potentially democratizing biological age measurement. New preprint: multimodal brain age prediction from 24k UK Biobank participants using 3D DenseNet reveals modality-specific disease risk predictions (diabetes, dementia) and causal lifestyle factors, adding nuance to brain age as a biomarker family. Recent additions: AI-enabled organoid platforms for drug testing; new anti-lipid antibody biomarkers for immune aging (Tufts); interpretable ML frailty model (APLR) using NHANES.